Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathy
Open Access
- 19 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 20 (7) , 1320-1328
- https://doi.org/10.1093/ndt/gfh837
Abstract
Background. The podocyte is bathed in an angiotensin II (AngII)-rich ultrafiltrate, but the impact of AngII on podocyte pathobiology is not well known. Because podocytes play a direct role in the glomerular basement membrane (GBM) thickening of diabetes, the α3(IV) collagen chain was examined. Podocyte expression of α3(IV) collagen may involve the transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF) systems. Methods. Cultured mouse podocytes were treated with various doses of AngII for selected periods of time, with or without inhibitors of TGF-β and VEGF signalling, SB-431542 and SU5416, respectively. TGF-β1 and VEGF were assayed by enzyme-linked immunosorbent assay (ELISA); α3(IV) collagen, TGF-β type II receptor and phospho-Smad2 were assayed by immunoblotting. Results. AngII ≥10−10 M was found to stimulate the production of α3(IV) collagen significantly in as short a time as 3 h. The expression of α3(IV) collagen was influenced by the TGF-β system, but AngII did not increase the podocyte's production of TGF-β1 ligand; rather, it increased the expression of the TGF-β type II receptor and activated the TGF-β signalling system through Smad2. Despite the TGF-β receptor upregulation, synergy between AngII and TGF-β1 to boost α3(IV) collagen production was not observed. However, blockade of TGF-β signalling with SB-431542 prevented AngII from stimulating α3(IV) collagen production. Podocyte expression of α3(IV) collagen was also increased by the autocrine activity of VEGF. Podocytes were stimulated to secrete VEGF by 10−10 M or higher AngII after 48 h. Blockade of the endogenous VEGF activity by SU5416 prevented AngII-stimulated α3(IV) collagen production. Conclusions. AngII stimulates the podocyte to produce α3(IV) collagen protein via mechanisms involving TGF-β and VEGF signalling. Alterations in α3(IV) collagen production may contribute to GBM thickening and perhaps proteinuria in diabetes.Keywords
This publication has 17 references indexed in Scilit:
- Podocyte-Derived Vascular Endothelial Growth Factor Mediates the Stimulation of α3(IV) Collagen Production by Transforming Growth Factor-β1 in Mouse PodocytesDiabetes, 2004
- Characterization of angiotensin II–receptor subtypes in podocytesJournal of Laboratory and Clinical Medicine, 2003
- Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db miceBiochemical and Biophysical Research Communications, 2003
- Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytesKidney International, 2002
- Rearrangements of the Cytoskeleton and Cell Contacts Induce Process Formation during Differentiation of Conditionally Immortalized Mouse Podocyte Cell LinesExperimental Cell Research, 1997
- The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanismsAmerican Journal of Kidney Diseases, 1997
- Angiotensin II Is Mitogenic for Cultured Rat Glomerular Endothelial CellsHypertension, 1996
- Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistryKidney International, 1994
- Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.Journal of Clinical Investigation, 1993
- Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.Journal of Clinical Investigation, 1990